Skip to main content
. Author manuscript; available in PMC: 2012 May 3.
Published in final edited form as: J Gastrointest Surg. 2008 Aug 16;12(11):1951–1960. doi: 10.1007/s11605-008-0640-6

Table 3.

Tumor Response and Outcomes

HACE HAE p Value
Morbidity, % 2.4 6.6 0.19
30-day mortality, % 0.8 1.8 0.60
Symptomatic, % 76 69 0.34
Symptoms improved, % 86 83 0.70
Survival—metastases dx 0.64
 Median, months 50.1 39.1
 5-year, % 43 35
Survival—1st embolization 0.79
 Median, months 25.5 25.7
 5-year, % 19 13